Hello OHDSI community,
We are building an ETL to transform medication administration records into OMOP drug_exposure.
In our source table, we have, among other things, ATC codes. OHDSI provides ATC to RxNorm ingredient mappings which can be used in the drug_exposure table.
Let’s assume the example of having concept abacavir – 300 mg – J05AF06 in the source.
In drug_exposure we do not have an “amount_value” field because this is derived from drug_strength. It does not work for RxNorm Ingredient concepts (i.e., abacavir - 1736971) since such concepts do not have a value for “amount_value”, hence we cannot preserve the dosage information attached to the drug (i.e., 300 mg)
On the OHDSI OMOP Github for the drug_concept_id field in drug_exposure table, it is mentioned that the preferable hierarchy is “Marketed Product, Branded Pack, Clinical Pack, Branded Drug, Clinical Drug, Branded Drug Component, Clinical Drug Component, Branded Drug Form, Clinical Drug Form and only if no other information is available Ingredient.” Of note: some of these include concepts from RxNorm Extension as well.
So we now made these mappings with Usagi get to a Clinical Drug (in this example, where available, we also map to higher-level hierarchical concepts) = concept ID 1736994.
Now onto our questions. Next, we want to populate drug_era but the script to create it requires RxNorm Ingredient concepts.
Do we need to make an additional mapping table in which we use the ATC to Ingredient mapping to populate the drug_era table?
Or is there any other way to get from this Clinical Drug (concept ID 1736994) to Ingredient? In Athena we noticed how this concept relates through the “Consists of (RxNorm)” link to concept ID 1736997, which next relates through “Has ingredient (RxNorm)” to concept ID 1736971 = Ingredient. However, we expect major performance issues if we build that in to the query…
We would be happy to hear your considerations, thanks!